A proposed overhaul of pharmacy practice has opened a fierce dispute between regulators and thousands of pharmaceutical technologists.
Draft 11 of Kenya’s Good Pharmacy Practice Guidelines would reportedly reserve the management of pharmacies in certain health facilities for degree-holding pharmacists. Diploma-trained pharmaceutical technologists could also face restrictions on handling narcotic and psychotropic medicines.
The Kenya Pharmaceutical Association has rejected the proposals, arguing that technologists were excluded from meaningful consultation during later stages of drafting.
The association says Kenya has approximately 10,533 licensed pharmaceutical technologists, compared with 2,931 licensed pharmacists and 2,559 Level Three health facilities. It argues that removing technologists from these facilities could create staffing gaps, particularly in rural counties.
Supporters of tighter regulation may argue that controlled medicines require stronger oversight and clearly defined professional responsibility. However, regulation must also account for the actual size and distribution of Kenya’s healthcare workforce.
The central question is therefore bigger than professional titles: will the proposed rules improve patient safety without reducing access to medicine?
Before adopting the guidelines, the Pharmacy and Poisons Board should publish the evidence behind the proposed changes and allow pharmacists, technologists, hospitals and patients to participate in a transparent review.
No comments yet. Be the first to share your thoughts.